FDA Import Refusal 799-9603810-5/11/1 — SATO PHARMACEUTICAL CO.,LTD.
The FDA refused shipment 799-9603810-5/11/1 from SATO PHARMACEUTICAL CO.,LTD. (Japan) on March 8, 2024. The refused product falls under Drugs and Biologics — NAPHAZOLINE HCL (ADRENERGIC). Cited charge: 75 This firm has 5 or more other import refusals on record.
Refusal Details
- Date
- March 8, 2024
- Country
- Japan
- Product Category
- Drugs and Biologics
- Product Code
- 60CAV46 NAPHAZOLINE HCL (ADRENERGIC)
- Charges
- 75